+971.7%
MRNA vs NTAP
+209.1%
+762.6%
-95.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 10y.
| Period | Portfolio | NTAP | Excess | Alpha |
|---|---|---|---|---|
| 1D | +1.3% | -1.2% | +2.5% | +1.5% |
| 7D | -13.8% | -8.5% | -5.3% | -12.1% |
| 30D | -17.7% | -19.0% | +1.3% | -14.0% |
| 3M | +14.3% | -12.3% | +26.6% | +17.1% |
| 6M | +336.0% | +41.9% | +294.1% | +275.5% |
| YTD | +575.9% | +61.4% | +514.6% | +454.9% |
| 1Y | +724.4% | +62.6% | +661.8% | +575.6% |
| 3Y | +160.8% | +131.7% | +29.0% | +90.5% |
| 5Y | -24.4% | +121.0% | -145.4% | -44.9% |
| All | +971.7% | +209.1% | +762.6% | +613.0% |
Cumulative growth
Daily Returns
Daily percentage return beside NTAP.
Daily Out/Under-Performance
Portfolio return minus NTAP return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × NTAP return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 10y: compounded portfolio wealth divided by compounded NTAP wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
10y analysis · Full analysis span regression · 6 months rolling